会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • Biomarkers for human papilloma virus-associated cancer
    • 人类乳头状瘤病毒相关癌症的生物标志物
    • US20090136486A1
    • 2009-05-28
    • US12220465
    • 2008-07-24
    • Dohun PyeonPaul F. LambertMichael A. NewtonPaul G. Ahlquist
    • Dohun PyeonPaul F. LambertMichael A. NewtonPaul G. Ahlquist
    • A61K39/395C12Q1/68A61P35/00G01N33/53
    • C12Q1/6886C12Q1/708C12Q2600/112C12Q2600/136
    • Cervical cancer cells and HPV+ head and neck cancer cells express three testis-specific genes not normally expressed in somatic cells: testicular cell adhesion molecule 1 (TCAM1), synaptonemal complex protein 2 (SYCP2) and stromal antigen 3 (STAG3). Among the three markers, TCAM1 and SYCP2 are early detection markers. Various methods for identifying a human or non-human animal as a candidate for further examination for cervical cancer, preneoplastic lesion for cervical cancer, head and neck cancer, or preneoplastic lesion for head and neck cancer are disclosed. Methods of detecting said cancers and preneoplastic lesions, methods of screening for drugs for treating said cancers and preneoplastic lesions, methods for monitoring the effectiveness of a treatment for said cancers, and methods of treating said cancers are also disclosed. Further disclosed are kits that can be used to practice the above methods.
    • 子宫颈癌细胞和HPV +头颈癌细胞表达体细胞无正常表达的三种睾丸特异性基因:睾丸细胞粘附分子1(TCAM1),突触核蛋白复合蛋白2(SYCP2)和基质抗原3(STAG3)。 在三个标记中,TCAM1和SYCP2是早期检测标记。 公开了用于鉴定人类或非人类动物作为子宫颈癌进一步检查,宫颈癌前肿瘤病变,头颈部癌症或头颈癌的癌前病变的候选者的各种方法。 检测所述癌症和癌前病变的方法,筛选用于治疗所述癌症和癌前病变的药物的方法,用于监测所述癌症治疗有效性的方法,以及治疗所述癌症的方法。 进一步公开的是可用于实施上述方法的试剂盒。
    • 5. 发明授权
    • Biomarkers for human papilloma virus-associated cancer
    • 人类乳头状瘤病毒相关癌症的生物标志物
    • US08012678B2
    • 2011-09-06
    • US12220465
    • 2008-07-24
    • Dohun PyeonPaul F. LambertMichael A. NewtonPaul G. Ahlquist
    • Dohun PyeonPaul F. LambertMichael A. NewtonPaul G. Ahlquist
    • G01N33/574C12Q1/00
    • C12Q1/6886C12Q1/708C12Q2600/112C12Q2600/136
    • Cervical cancer cells and HPV+ head and neck cancer cells express three testis-specific genes not normally expressed in somatic cells: testicular cell adhesion molecule 1 (TCAM1), synaptonemal complex protein 2 (SYCP2) and stromal antigen 3 (STAG3). Among the three markers, TCAM1 and SYCP2 are early detection markers. Various methods for identifying a human or non-human animal as a candidate for further examination for cervical cancer, preneoplastic lesion for cervical cancer, head and neck cancer, or preneoplastic lesion for head and neck cancer are disclosed. Methods of detecting said cancers and preneoplastic lesions, methods of screening for drugs for treating said cancers and preneoplastic lesions, methods for monitoring the effectiveness of a treatment for said cancers, and methods of treating said cancers are also disclosed. Further disclosed are kits that can be used to practice the above methods.
    • 子宫颈癌细胞和HPV +头颈癌细胞表达体细胞无正常表达的三种睾丸特异性基因:睾丸细胞粘附分子1(TCAM1),突触蛋白复合蛋白2(SYCP2)和基质抗原3(STAG3)。 在三个标记中,TCAM1和SYCP2是早期检测标记。 公开了用于鉴定人类或非人类动物作为子宫颈癌进一步检查,宫颈癌前肿瘤病变,头颈部癌症或头颈癌的癌前病变的候选者的各种方法。 检测所述癌症和癌前病变的方法,筛选用于治疗所述癌症和癌前病变的药物的方法,用于监测所述癌症治疗有效性的方法,以及治疗所述癌症的方法。 进一步公开的是可用于实施上述方法的试剂盒。